National Healthcare (NYSE: NHC) corrects director option grant price

Rhea-AI Filing Summary

National Healthcare Corp director William A. Adams received a grant of options to purchase 7,500 shares of common stock. The options have an exercise price of $171.42 per share, matching the closing price on May 7, 2026, and are scheduled to expire on May 6, 2030. This Form 4/A corrects a previous filing that had mistakenly reported the option price as $0.00, while the number of options and underlying shares remains 7,500.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Adams William A.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock [2026 Grant]	7,500	$0.00	--

Holdings After Transaction: Option to Purchase Common Stock [2026 Grant] — 7,500 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 7,500 options Exercise price: $171.42 per share Underlying shares: 7,500 shares +3 more

6 metrics

Options granted 7,500 options Option to Purchase Common Stock [2026 Grant]

Exercise price $171.42 per share Closing price as of May 7, 2026

Underlying shares 7,500 shares Common stock underlying the options

Expiration date May 6, 2030 Option expiration for 2026 grant

Options held after grant 7,500 options Total derivative position following transaction

Transaction code A Grant, award, or other acquisition of derivative security

Key Terms

Option to Purchase Common Stock, exercise price, Form 4/A, Grant, award, or other acquisition

4 terms

Option to Purchase Common Stock financial

"security_title: "Option to Purchase Common Stock [2026 Grant]""

exercise price financial

"The price is the closing as of 5/7/2026 ($171.42)"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Form 4/A regulatory

"this is corrected on this Form 4/A."

Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Adams William A.

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TENNESSEE 37130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/07/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock [2026 Grant]	$171.42(1)	05/07/2026		A		7,500		05/07/2026	05/06/2030	Common Stock	7,500	$0	7,500	D

Explanation of Responses:

1. previous Form 4 price of the option was not entered correctly it was originally entered at $0.00. The price is the closing as of 5/7/2026 ($171.42) this is corrected on this Form 4/A.

	/s/ William A. Adams	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did National Healthcare Corp (NHC) report in this Form 4/A?

National Healthcare Corp reported an option grant to director William A. Adams for 7,500 shares. The options relate to common stock, are compensation-related, and reflect a routine grant rather than an open-market purchase or sale of shares.

How many options did William A. Adams receive from National Healthcare Corp (NHC)?

William A. Adams received options for 7,500 shares of National Healthcare Corp common stock. These options give him the right to buy up to 7,500 shares at a fixed exercise price, subject to the option terms and expiration date.

What is the exercise price of the options granted to the NHC director?

The options granted to the National Healthcare Corp director have an exercise price of $171.42 per share. According to the filing, this amount equals the closing stock price on May 7, 2026, and replaces a previously misreported $0.00 figure.

When do William A. Adams’s National Healthcare Corp (NHC) options expire?

The options granted to William A. Adams are scheduled to expire on May 6, 2030. After that date, he can no longer use these options to purchase National Healthcare Corp common stock under this specific 2026 grant.

What correction does this Form 4/A make for National Healthcare Corp (NHC)?

This Form 4/A corrects the reported option exercise price from $0.00 to $171.42. The footnote explains the original Form 4 omitted the proper price, which should match the May 7, 2026 closing stock price for the 7,500-share option grant.

Is the NHC Form 4/A transaction an open-market buy or sell of shares?

No, the filing reports a grant of stock options, not an open-market trade. It reflects compensation to director William A. Adams in the form of options, with 7,500 underlying shares and an exercise price of $171.42 per share.